Viewing Study NCT05391360

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-03-05 @ 6:28 AM
Study NCT ID: NCT05391360
Status: COMPLETED
Last Update Posted: 2023-04-12
First Post: 2022-05-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study
Sponsor: Sunshine Lake Pharma Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatitis B, Chronic View
Keywords: